share_log

Society Pass Analyst Ratings

Benzinga ·  Nov 1, 2023 13:05
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/01/2023 712.13% Greenridge Global → $3 Initiates Coverage On → Buy
07/11/2023 847.48% Ascendiant Capital → $3.5 Initiates Coverage On → Buy
03/27/2023 644.45% Maxim Group $5 → $2.75 Maintains Buy
07/26/2022 2065.67% Spartan Securities Group → $8 Initiates Coverage On → Buy
05/19/2022 1253.55% Maxim Group $9 → $5 Maintains Buy
02/24/2022 2336.38% Maxim Group → $9 Initiates Coverage On → Buy

What is the target price for Society Pass (SOPA)?

The latest price target for Society Pass (NASDAQ: SOPA) was reported by Greenridge Global on November 1, 2023. The analyst firm set a price target for $3.00 expecting SOPA to rise to within 12 months (a possible 712.13% upside). 3 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Society Pass (SOPA)?

The latest analyst rating for Society Pass (NASDAQ: SOPA) was provided by Greenridge Global, and Society Pass initiated their buy rating.

When is the next analyst rating going to be posted or updated for Society Pass (SOPA)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Society Pass, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Society Pass was filed on November 1, 2023 so you should expect the next rating to be made available sometime around November 1, 2024.

Is the Analyst Rating Society Pass (SOPA) correct?

While ratings are subjective and will change, the latest Society Pass (SOPA) rating was a initiated with a price target of $0.00 to $3.00. The current price Society Pass (SOPA) is trading at is $0.37, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment